Ispecimen Inc (ISPC)

$0.62 -0.02 (-2.41%)
Market Cap 6.21M
Revenue (ttm) 9.29M
Net Income (ttm) -12.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -134.55%
Debt to Equity Ratio 0.00
Volume 181,400
Avg Vol 8,369,742
Day's Range N/A - N/A
Shares Out 9.77M
Stochastic %K 31%
Beta 1.76
Analysts Strong Buy
Price Target $4.25

Company Profile

iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers worldwide. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. Its marketplace offers human biospecimens, including Biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal m...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 301 6700
Address:
8 Cabot Road, Woburn, United States
ArlendMcfarland
ArlendMcfarland Nov. 14 at 4:24 PM
$ISPC getting close
0 · Reply
conart
conart Nov. 14 at 4:06 PM
$ISPC https://www.lw.com/en/practices/white-collar-defense-and-investigations/financial-fraud-defense You all contact this or another lawyer you choose. They are specialized for SEC and DOJ investigations and white collar crimes.
0 · Reply
bionicman1969
bionicman1969 Nov. 14 at 10:37 AM
$ISPC removing from watch list sub dollar good luck Sell
0 · Reply
Pratik2024
Pratik2024 Nov. 13 at 9:51 PM
$AQMS $ISPC $MWYN $STI $UGRO Put my money for MWYN
0 · Reply
WSharkTrade
WSharkTrade Nov. 13 at 4:10 PM
$AQMS $ISPC $MWYN $STI $UGRO
0 · Reply
conart
conart Nov. 12 at 10:10 PM
$ISPC don't believe the clowns saying bullish and buying more, this stock makes you live the hell if you touch, every day is a new red day.
0 · Reply
ArlendMcfarland
ArlendMcfarland Nov. 12 at 6:33 PM
$ISPC loading more, waiting
0 · Reply
CoolCatTrades
CoolCatTrades Nov. 12 at 3:07 PM
$ISPC got more
0 · Reply
artmas92
artmas92 Nov. 11 at 6:29 PM
$ISPC New CEO: https://www.tipranks.com/news/company-announcements/ispecimen-appoints-katharyn-field-as-new-ceo
0 · Reply
jvanand2k
jvanand2k Nov. 11 at 3:05 AM
$ISPC will it ever go $1 or just dump?
0 · Reply
Latest News on ISPC
iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions

Sep 4, 2025, 4:05 PM EDT - 2 months ago

iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions

iSpecimen Announces Completion of Milestone 1 in Digital Transformation Journey with Salestack Platform

Aug 21, 2025, 8:00 AM EDT - 3 months ago

iSpecimen Announces Completion of Milestone 1 in Digital Transformation Journey with Salestack Platform

iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow

Aug 7, 2025, 4:05 PM EDT - 3 months ago

iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow

iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market

Aug 4, 2025, 6:45 PM EDT - 3 months ago

iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market

iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market

Jul 31, 2025, 4:06 PM EDT - 3 months ago

iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market

Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

Jul 28, 2025, 4:35 PM EDT - 3 months ago

Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering

Jul 28, 2025, 4:30 PM EDT - 3 months ago

Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering

iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

Jul 25, 2025, 1:53 PM EDT - 3 months ago

iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering

Jul 24, 2025, 8:30 AM EDT - 4 months ago

iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering

iSpecimen Secures Suppliers for COVID-style hMPV Outbreak

Jan 16, 2025, 4:01 PM EST - 10 months ago

iSpecimen Secures Suppliers for COVID-style hMPV Outbreak

iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

Dec 20, 2024, 8:30 AM EST - 11 months ago

iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

Dec 13, 2024, 7:30 AM EST - 1 year ago

iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

iSpecimen Appoints Robert Lim as CEO and Director

Dec 12, 2024, 5:11 PM EST - 1 year ago

iSpecimen Appoints Robert Lim as CEO and Director

iSpecimen Named Top Competitor in $4.4 Billion USD Market

Nov 8, 2024, 7:30 AM EST - 1 year ago

iSpecimen Named Top Competitor in $4.4 Billion USD Market

iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually

Nov 7, 2024, 7:30 AM EST - 1 year ago

iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

Oct 31, 2024, 3:07 PM EDT - 1 year ago

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

Oct 30, 2024, 8:30 AM EDT - 1 year ago

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

iSpecimen Secures $1 Million Loan; Appoints Three New Board Members

Sep 26, 2024, 7:30 AM EDT - 1 year ago

iSpecimen Secures $1 Million Loan; Appoints Three New Board Members

iSpecimen Announces 1-for-20 Reverse Stock Split

Sep 11, 2024, 4:30 PM EDT - 1 year ago

iSpecimen Announces 1-for-20 Reverse Stock Split

iSpecimen Inc. (ISPC) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 7:14 AM EDT - 1 year ago

iSpecimen Inc. (ISPC) Q2 2024 Earnings Call Transcript

iSpecimen Reports Second Quarter 2024 Results

Aug 6, 2024, 7:30 AM EDT - 1 year ago

iSpecimen Reports Second Quarter 2024 Results

iSpecimen Inc. (ISPC) Q1 2024 Earnings Call Transcript

May 12, 2024, 8:24 AM EDT - 1 year ago

iSpecimen Inc. (ISPC) Q1 2024 Earnings Call Transcript

iSpecimen Reports First Quarter 2024 Results

May 7, 2024, 7:30 AM EDT - 1 year ago

iSpecimen Reports First Quarter 2024 Results

iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024

Apr 25, 2024, 8:00 AM EDT - 1 year ago

iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024

iSpecimen Inc. (ISPC) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 10:40 AM EDT - 1 year ago

iSpecimen Inc. (ISPC) Q4 2023 Earnings Call Transcript

iSpecimen Reports Full Year 2023 Results

Mar 14, 2024, 8:00 AM EDT - 1 year ago

iSpecimen Reports Full Year 2023 Results

iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call

Mar 12, 2024, 7:07 PM EDT - 1 year ago

iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call

iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024

Mar 5, 2024, 4:30 PM EST - 1 year ago

iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024

iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research

Jan 23, 2024, 7:30 AM EST - 1 year ago

iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research

iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024

Jan 18, 2024, 8:11 AM EST - 1 year ago

iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024

iSpecimen Strengthens Global Oncology Biospecimen Offering

Dec 7, 2023, 7:30 AM EST - 2 years ago

iSpecimen Strengthens Global Oncology Biospecimen Offering

iSpecimen Inc. (ISPC) Q3 2023 Earnings Call Transcript

Nov 3, 2023, 4:39 PM EDT - 2 years ago

iSpecimen Inc. (ISPC) Q3 2023 Earnings Call Transcript

iSpecimen Reports Third Quarter 2023 Financial and Operating Results

Nov 2, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Reports Third Quarter 2023 Financial and Operating Results

iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research

Oct 26, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research

iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially

Oct 23, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially

iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers

Sep 28, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers

iSpecimen Expands Provider Network to Enhance Support for Women's Health Research

Sep 13, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Expands Provider Network to Enhance Support for Women's Health Research

iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability

Sep 6, 2023, 4:05 PM EDT - 2 years ago

iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability

Top 5 Health Care Stocks That May Explode In Q3 - BioVie (NASDAQ:BIVI), Galera Therapeutics (NASDAQ:GRTX)

Sep 6, 2023, 7:36 AM EDT - 2 years ago

Top 5 Health Care Stocks That May Explode In Q3 - BioVie (NASDAQ:BIVI), Galera Therapeutics (NASDAQ:GRTX)

BIVI OMIC

iSpecimen Launches New Virtual Cancer Sequencing Procurement Program

Aug 30, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Launches New Virtual Cancer Sequencing Procurement Program

iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers

Aug 16, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers

iSpecimen Introduces New Marketplace Functionality to Streamline Access to Clinical Remnant Samples for Researchers

Aug 9, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Introduces New Marketplace Functionality to Streamline Access to Clinical Remnant Samples for Researchers

iSpecimen Inc. (ISPC) Q2 2023 Earnings Call Transcript

Aug 5, 2023, 10:22 AM EDT - 2 years ago

iSpecimen Inc. (ISPC) Q2 2023 Earnings Call Transcript

iSpecimen Reports Second Quarter 2023 Financial and Operating Results

Aug 2, 2023, 7:00 AM EDT - 2 years ago

iSpecimen Reports Second Quarter 2023 Financial and Operating Results

iSpecimen to Report Second Quarter 2023 Results on August 2, 2023

Jul 25, 2023, 7:30 AM EDT - 2 years ago

iSpecimen to Report Second Quarter 2023 Results on August 2, 2023

Thirteen New Biospecimen Suppliers Added to iSpecimen's Proprietary Provider Network

Jul 6, 2023, 7:30 AM EDT - 2 years ago

Thirteen New Biospecimen Suppliers Added to iSpecimen's Proprietary Provider Network

iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on June 1, 2023

May 23, 2023, 7:30 AM EDT - 2 years ago

iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on June 1, 2023

iSpecimen Inc. (ISPC) Q1 2023 Earnings Call Transcript

May 6, 2023, 6:25 PM EDT - 2 years ago

iSpecimen Inc. (ISPC) Q1 2023 Earnings Call Transcript

iSpecimen Reports First Quarter 2023 Results

May 4, 2023, 7:00 AM EDT - 2 years ago

iSpecimen Reports First Quarter 2023 Results

iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023

Apr 24, 2023, 7:30 AM EDT - 2 years ago

iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023

ArlendMcfarland
ArlendMcfarland Nov. 14 at 4:24 PM
$ISPC getting close
0 · Reply
conart
conart Nov. 14 at 4:06 PM
$ISPC https://www.lw.com/en/practices/white-collar-defense-and-investigations/financial-fraud-defense You all contact this or another lawyer you choose. They are specialized for SEC and DOJ investigations and white collar crimes.
0 · Reply
bionicman1969
bionicman1969 Nov. 14 at 10:37 AM
$ISPC removing from watch list sub dollar good luck Sell
0 · Reply
Pratik2024
Pratik2024 Nov. 13 at 9:51 PM
$AQMS $ISPC $MWYN $STI $UGRO Put my money for MWYN
0 · Reply
WSharkTrade
WSharkTrade Nov. 13 at 4:10 PM
$AQMS $ISPC $MWYN $STI $UGRO
0 · Reply
conart
conart Nov. 12 at 10:10 PM
$ISPC don't believe the clowns saying bullish and buying more, this stock makes you live the hell if you touch, every day is a new red day.
0 · Reply
ArlendMcfarland
ArlendMcfarland Nov. 12 at 6:33 PM
$ISPC loading more, waiting
0 · Reply
CoolCatTrades
CoolCatTrades Nov. 12 at 3:07 PM
$ISPC got more
0 · Reply
artmas92
artmas92 Nov. 11 at 6:29 PM
$ISPC New CEO: https://www.tipranks.com/news/company-announcements/ispecimen-appoints-katharyn-field-as-new-ceo
0 · Reply
jvanand2k
jvanand2k Nov. 11 at 3:05 AM
$ISPC will it ever go $1 or just dump?
0 · Reply
Bazzzigar
Bazzzigar Nov. 10 at 4:08 PM
$ISPC RXRX
0 · Reply
Tradingistheway
Tradingistheway Nov. 10 at 7:38 AM
$ISPC $5
1 · Reply
DDUDDU
DDUDDU Nov. 8 at 7:23 AM
$ISPC iSpecimen (ISPC, iSpecimen Inc. ) announced the change of CEO and director. According to the U.S. Securities and Exchange Commission on the 7th, on November 7, 2025, the board of directors of iSpeshman is Ms. Katharyn Field was appointed as CEO, secretary and financial director, and it will take effect immediately. Ms. Field continues to serve as the president of the company. The same day, Mr. Robert Bradley Lim stepped down as CEO, secretary, and financial director, and also resigned as a director.
0 · Reply
Bazzzigar
Bazzzigar Nov. 7 at 7:46 PM
$ISPC ABAT DVLT
0 · Reply
DDUDDU
DDUDDU Nov. 7 at 4:30 PM
$ISPC It’s unfortunate that things turned out just as I expected Now all the clowns who were shouting “bullish” and urging people to buy have disappeared
0 · Reply
NormalOne1
NormalOne1 Nov. 7 at 4:24 PM
$ISPC If this recent Solana promotion was used for a pump-and-dump, then it means intentional dissemination of false information, and the SEC should consider launching an investigation, while investors may also need to consider a class action lawsuit
0 · Reply
GrimReaper1987
GrimReaper1987 Nov. 7 at 4:01 PM
$ISPC The reverse split has been approved but not yet implemented, and if the price falls below $0.44, the stock could be at risk of being delisted
0 · Reply
amir10
amir10 Nov. 7 at 2:50 PM
$ISPC ugly stock
0 · Reply
PennyStockGod11
PennyStockGod11 Nov. 7 at 11:30 AM
$ISPC Double Bottom
0 · Reply
LightbulbTrades
LightbulbTrades Nov. 7 at 12:23 AM
$ISPC round 2 ?
0 · Reply
conart
conart Nov. 6 at 11:23 PM
$ISPC This is the best way I can help if you own this stock. Go to "sec.gov/submit-tip-or-compl..." and file a complaint anonymously. you don't have to share your info if you don't wan to. Stand up and let your voice heard !!!
0 · Reply
GrimReaper1987
GrimReaper1987 Nov. 6 at 7:25 PM
$ISPC From now on, anyone calling this stock “bullish” is a delusional psycho.
0 · Reply